Martingale Asset Management’s Sana Biotechnology SANA Stock Holding History

Martingale Asset Management’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-42,338	Closed	-$231K	–	837
2024 Q2	$231K	Sell	42,338 -6,858	-14%	-$54.6K	0.01%	736
2024 Q1	$492K	Sell	49,196 -10,507	-18%	-$78.7K	0.01%	620
2023 Q4	$244K	Hold	59,703	–	–	0.01%	729
2023 Q3	$231K	Sell	59,703 -23	-0%	-$124	﹤0.01%	726
2023 Q2	$356K	Buy	59,726 +2,811	+5%	+$16.2K	0.01%	671
2023 Q1	$186K	Hold	56,915	–	–	﹤0.01%	788
2022 Q4	$225K	Buy	56,915 +700	+1%	+$3.42K	﹤0.01%	771
2022 Q3	$338K	Hold	56,215	–	–	0.01%	696
2022 Q2	$362K	Buy	56,215 +17,529	+45%	+$112K	0.01%	709
2022 Q1	$320K	Buy	+38,686	New	+$313K	﹤0.01%	715

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return

Martingale Asset Management's SANA Position: Q3 2024 in Review

Martingale Asset Management sold out of Sana Biotechnology (SANA) in Q3 2024, closing a stake of 42,338 shares — an estimated $231K sold.

Martingale Asset Management first reported a position in SANA in Q1 2022 and held it in 10 quarters. The position peaked at $492K in Q1 2024. 155 funds tracked by Wall St. Rank hold SANA as of Q3 2024.

Martingale Asset Management reported no remaining Sana Biotechnology position as of Q3 2024 after selling out during the quarter.
Martingale Asset Management sold 42,338 Sana Biotechnology shares in Q3 2024, an estimated $231K.
Martingale Asset Management first reported a position in Sana Biotechnology in Q1 2022 and held it in 10 quarters.
Martingale Asset Management's Sana Biotechnology position peaked at $492K in Q1 2024.
155 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2024.

Based on Martingale Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.